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Gastroschisis is typically considered an isolated anterior abdominal wall defect with a low rate of sec-
ondary gastrointestinal anomalies. However, other congenital anomalies associated with gastroschisis
may be more common than is generally appreciated. We report a case of term neonate with gastroschisis
and congenital hydrocephalus who developed central diabetes insipidus. This case highlights the
complexity of managing neonates with central diabetes, which often requires multiple pharmacologic
agents such as vasopressin and thiazide diuretics. Although rare, assessing patients with gastroschisis for
other anomalies is important since conditions like hydrocephalus may complicate medical management.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Gastroschisis, a full-thickness abdominal wall defect usually
located to the right of the umbilical cord, is associated with other
anomalies in approximately 5e32% of cases [1,2]. The prevalence of
gastroschisis is estimated at 3e5 per 10,000 births compared to
omphalocele which has a prevalence of 1.5e3 per 10,000 and is
associated with anomalies in up to 50%e70% of cases [3]. Neonates
with gastroschisis, similar to those with omphalocele, require a
thorough assessment for associated non-intestinal anomalies since
these malformations may complicate management. We describe a
rare case of a neonate with gastroschisis complicated by hydro-
cephalus and central diabetes insipidus (CDI) with a focused dis-
cussion on the surgical and medical management.1. Case
A 3400 g male with prenatal ultrasound diagnosis of gastro-
schisis and hydrocephalus was delivered without complications by
planned cesarean section at 38 weeks’ gestation because of mac-
rocephaly. An initial prenatal ultrasound at 27 weeks’ gestation
identiﬁed mild ventriculomegaly and an abdominal wall defect toBY-NC-ND license (http://
ivision of Neonatology, Uni-
195-6320, USA. Tel.: þ1 206
).
Published by Elsevier Inc. All rightthe right of the umbilical cord insertion site consistent with gas-
troschisis. A 34-weeks’ gestation ultrasound demonstrated that the
abdominal wall defect was unchanged with normal bowel caliber
and no evidence of obstruction; however, there was severe ven-
triculomegaly with new dilation of the third ventricle consistent
with, but not speciﬁc for aqueductal stenosis. The patient’s mother
had genetic analysis with cell free DNA, which was normal. She
declined amniocentesis for cytogenetics or microarray because it
would not change her management of the pregnancy. After birth
the patient was transferred to our institution for surgical repair of
his gastroschisis. His exam was signiﬁcant for an anterior abdom-
inal wall defect consistent with gastroschisis, and an enlarged oc-
cipital-frontal circumference (40 cm,100th percentile), without any
facial dysmorphisms suggestive of an underlying syndrome. Hewas
found to have distal ileal atresia and subsequently underwent un-
complicated closure of the gastroschisis with end ileostomy and
ileal mucous ﬁstula.
A cranial ultrasound on day of age one demonstrated moderate
to severe hydrocephalus involving the lateral ventricles. A sub-
sequent MRI showed severe hydrocephalus of the lateral and third
ventricles with cerebral aqueductal obstruction as well as partial
lissencephaly and small bilateral optic pathways without evi-
dence of septo-optic dysplasia or an intracranial tumor (Fig. 1).
A screening renal ultrasound and echocardiogram were normal.
The infant had no apneic, bradycardic, or cyanotic events and did
not require any respiratory support.
On day of age 2, the infant developed increasing urine output of
4.5ml/kg/hr with a total ﬂuid requirement of 175ml/kg/day. He hads reserved.
Fig. 1. MR images of the brain in an infant with congenital hydrocephalus and gastroschisis. A) Axial T2 MR image demonstrating severe hydrocephalus involving the lateral
ventricles with prominent atria. B) Sagittal three-dimensional MR constructive interference in steady state (CISS) demonstrating cerebral aqueduct obstruction (arrow) and ven-
triculomegaly. C) MR Coronal Three-Dimensional, T1-Weighted Gradient-Echo (MP RAGE) demonstrating small optic nerves (arrows) and ventriculomegaly.
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the diagnosis of diabetes insipidus based on an elevated sodium
level of 162 mEq/L, serum osmolality of 303 mOsm/kg, and urine
osmolality of 269mOsm/kg. The endocrinology teamwas consulted
and the infant was started on volume replacement to compensate
for insensible losses due to polyuria (1:1 replacement with 1/2
normal saline to match urine output) together with his total
parenteral nutrition maintenance ﬂuids, which were held constant
to ensure the infant received adequate nutritional intake despite
ﬂuctuating ﬂuid requirements from his CDI. Additionally, he was
also started on a vasopressin drip to maintain stable urine output
and sodium levels. On day of age 3, the vasopressin drip was
increased because his urine output was elevated to 16 ml/kg/hr
requiring total ﬂuids of 520 ml/kg/day.
The CDI was presumed secondary to hydrocephalus. The infant
underwent endoscopic third ventriculostomywith bilateral choroid
plexus cauterization and placement of a ventricular reservoir.
Following the procedure his urine output and sodium levels
normalized presumed secondary to increasing endogenous anti-
diuretic hormone secretion. His vasopressin drip was weaned off
and he was transitioned to intravenous chlorothiazide per endo-
crinology recommendations. The chlorothiazide was titrated to a
dose of 5 mg/kg twice daily to achieve normal urine output and
sodium levels. The following week he was weaned off the
chlorothiazide.
Biweekly cranial ultrasounds demonstrated stable ventricular
size indicating effective cerebrospinal ﬂuid drainage. However, af-
ter one month the infant developed cerebrospinal ﬂuid leakage
from the surgical site with increasing ventriculomegaly on cranial
ultrasound indicating failure of the endoscopic third ven-
triculostomy and choroid plexus cauterization. He subsequently
underwent uncomplicated removal of the ventricular reservoir
with placement of a ventriculoatrial shunt since he was not a
candidate for a ventriculoperitoneal (VP) shunt given his recent
history of abdominal surgery. Around the time of his shunt place-
ment, he again developed symptoms consistent with CDI based on
high serum osmolality and sodium levels with low urine osmolality
and sodium levels. He was started on daily enteral free water
replacement and his laboratory values normalized.
Ophthalmological evaluation demonstrated bilateral optic nerve
hypoplasia with concern for severe vision loss. A genetics consult
did not lead to a unifying cause of his anomalies and a singlenucleotide polymorphism array study was normal. DNA was
banked for potential future analysis. The infant was slowly
advanced from nasogastric tube gavage feeds to expressed breast
milk nipple feeds of 170 ml/kg/day plus 20 ml/kg/day of free water
and was discharged home at 44 weeks’ corrected gestation age.
2. Discussion
Non-intestinal anomalies are common in infants with ompha-
loceles, but are rarely reported in infants with gastroschisis [4].
Recent literature suggests that associated anomalies should be
considered in gastroschisis cases. A retrospective analysis of
3,806,299 Texas births from 1999 to 2008 comparing the preva-
lence of associated anomalies among patients with gastroschisis
and omphaloceles, found that 32% of patients with gastroschisis
had associated anomalies versus 80% with omphaloceles [2]. The
most common anomalies associated with gastroschisis included
urogenital (24%), musculoskeletal (21%), and cardiac (15%) defects.
Only 7.2% of infants with gastroschisis had anomalies that involved
the central nervous system of which 1.2% had hydrocephalus [2].
We report a rare case of gastroschisis with hydrocephalus further
complicated by CDI without evidence of an underlying genetic
abnormality based on single nucleotide polymorphism array. In
this case, we speculate that resolution of the CDI was likely sec-
ondary to treatment of the hydrocephalus with third ven-
triculostomy, as evidenced by stable cranial ultrasounds with
diminishing need for vasopressin and chlorothiazide following
surgical intervention. The mechanism by which hydrocephalus
causes CDI remains unknown, but may be related to elevated
intracranial pressure.
Literature describing an association between hydrocephalus and
CDI in neonates is sparse. One case report documented a preterm
neonate who developed intraventricular hemorrhage and post-
hemorrhagic hydrocephalus who subsequently developed CDI
requiring intranasal desmopressin [5]. Management of CDI in in-
fants can be challenging and early consultation with pediatric
endocrinology is recommended with close monitoring of urine
output and sodium levels. Infants with CDI excrete excessive
quantities of very dilute, but otherwise normal urine, resulting from
impaired synthesis and secretion of antidiuretic hormone by the
hypothalamus and posterior pituitary. Vasopressin is an appro-
priate initial therapy for central diabetes insipidus with transition
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stabilized [6]. Although the exact anti-diuretic mechanisms in the
setting of CDI are not known, chlorothiazide, a thiazide diuretic,
inhibits the sodium-chloride co-transporter in the renal distal
convoluted tubule and is thought to have a paradoxical antidiuretic
action related to increased renal sodium excretion [7]. Increased
sodium loss produces extracellular volume contraction leading to
decreased glomerular ﬁltration rate and increased proximal tubular
sodium and water reabsorption.
Along with medical management directed at maintaining
normal urine output and sodium levels, CDI in patients with hy-
drocephalus may be treated with neurosurgical interventionwith a
shunt or ventriculostomy. Although VP shunt placement is a com-
mon treatment for hydrocephalus, literature is lacking on the utility
of VP shunts in patients with gastroschisis. Following gastroschisis
repair, a number of factors could limit the effectiveness of a VP
shunt including the technical challenge of placing a VP shunt into
an underdeveloped abdominal wall cavity ﬁlled with swollen
bowel, a risk for leakage through the gastroschisis repair site, and
an increased risk for ﬂuid pockets and pseudocyst formation due to
abdominal cavity inﬂammation.
Thus, for patients with gastroschisis and hydrocephalus who fail
endoscopic third ventriculostomy and choroid plexus cauterization,
ventricular atrial shunts are likely the most appropriate treatment.
A high index of suspicion may be required to identify other
anomalies in newborns with gastroschisis, but detection may beaugmented by a screening ultrasound of the brain, heart, and kid-
neys. Infants with gastroschisis complicated by hydrocephalus
should be closely monitored for the development of CDI and may
require neurosurgical intervention along with medical manage-
ment to correct ﬂuid and electrolyte imbalances.
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